Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:719824.
doi: 10.1155/2015/719824. Epub 2015 Oct 13.

The Effects of Reduction Mammaplasty on Serum Leptin Levels and Insulin Resistance

Hakan Uzun  1 , Ozan Bitik  1 , Yahya Baltu  2 , Çiğdem Sönmez  3 , Ayşegül Öztürk Kaymak  4
Affiliations

The Effects of Reduction Mammaplasty on Serum Leptin Levels and Insulin Resistance

Hakan Uzun et al. Int J Endocrinol. 2015.

Abstract

Background. The reduction mammaplasty has been a well-executed and known procedure in which considerable amount of fatty tissue is removed from the body. The authors aimed to show the effects of the reduction mammaplasty on serum leptin levels and insulin resistance. Methods. 42 obese female patients who had gigantomastia were operated on. We recorded patients' demographic and preoperative data, including age, weight, height, and body mass index. Fasting serum leptin, glucose, and insulin levels were noted. Homeostasis model assessment scores were calculated. At the postoperative 8th week, patients were reevaluated in terms of above parameters assessing the presence of any difference. Results. Serum leptin levels were decreased postoperatively and the decrease was statistically significant. We were able to show a decrease in homeostasis model assessment score, which indicated an increase in insulin sensitivity, and this change was statistically significant. A significant correlation between body mass index and leptin change was found postoperatively. Conclusion. Reduction mammaplasty is not solely an aesthetic procedure but it decreases serum leptin levels and increases insulin sensitivity, which may help obese women to reduce their cardiovascular risk.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Association between serum leptin levels and type of reduction mammaplasty.
See this image and copyright information in PMC

References

    1. Kip K. E., Marroquin O. C., Kelley D. E., et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004;109(6):706–713. doi: 10.1161/01.cir.0000115514.44135.a8. - DOI - PubMed
    1. Michalakis K., le Roux C. Gut hormones and leptin: impact on energy control and changes after bariatric surgery—what the future holds. Obesity Surgery. 2012;22(10):1648–1657. doi: 10.1007/s11695-012-0698-9. - DOI - PubMed
    1. Appachi S., Kashyap S. R. Adiposopathy and cardiovascular disease: the benefits of bariatric surgery. Current Opinion in Cardiology. 2013;28(5):540–546. doi: 10.1097/hco.0b013e3283642a33. - DOI - PubMed
    1. Matarasso A., Kim R. W., Kral J. G. The impact of liposuction on body fat. Plastic and Reconstructive Surgery. 1998;102(5):1686–1689. doi: 10.1097/00006534-199810000-00057. - DOI - PubMed
    1. Chaouat M., Levan P., Lalanne B., Buisson T., Nicolau P., Mimoun M. Abdominal dermolipectomies: early postoperative complications and long-term unfavorable results. Plastic and Reconstructive Surgery. 2000;106(7):1614–1618. doi: 10.1097/00006534-200012000-00029. - DOI - PubMed

LinkOut - more resources